Company / Operating Margin
Zomedica Corp. Operating Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-263.4%
FY2025
5-year range
-263.4% / -115.8%
FY2022-FY2025
Trend
-40.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has declined for 3 consecutive years, from -115.8% in FY2022 to -263.4% in FY2025.
Based on SEC 10-K filings.
-263.4% in FY2025 with a 3-year CAGR of -147.6%.
Declined from -171.8% to -263.4% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -147.6pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- Zomedica Corp.'s operating margin has declined for 3 consecutive years.
- In FY2025, operating margin decreased 40.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -263.4% | -40.8% |
| FY2024 | -187.1% | -8.9% |
| FY2023 | -171.8% | -48.4% |
| FY2022 | -115.8% | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026